Measuring bladder permeability with MRI using a novel contrast agent formulation
Ended Project Grant Awarded Last action
- Award ID
- R41DK108397
- Recipient
-
Lipella Pharmaceuticals Inc. UEI JBVNWFNEEV59
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $224,999
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Pittsburgh, PA 15217, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | -$50,000 | |
| Amendment | $50,000 | |
| Original award | $224,999 |
Quick answers
Who received award R41DK108397?
R41DK108397 was awarded to Lipella Pharmaceuticals Inc. by National Institutes of Health (Department of Health and Human Services) on September 20, 2015.
How much is award R41DK108397 worth?
$224,999 has been obligated on R41DK108397.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award